We are live on ! Find out more
Jacobs Levy Equity Management

Jacobs Levy Equity Management Portfolio holdings

AUM $23.8B
1-Year Est. Return 25.4%
This Fund
S&P 500
This Quarter Est. Return
+9.96%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$25.2B
AUM Growth
-$335M
Cap. Flow
-$2.05B
Cap. Flow %
-8.13%
Top 10 Hldgs %
26.87%
Holding
1,147
New
127
Increased
298
Reduced
504
Closed
194

Top Buys

Rank Stock Value
1
ALNY icon
Alnylam Pharmaceuticals
ALNY
+$160M
2
MAS icon
Masco
MAS
+$134M
3
LRCX icon
Lam Research
LRCX
+$112M
4
CPNG icon
Coupang
CPNG
+$101M
5
NU icon
Nu Holdings
NU
+$98.3M

Top Sells

Rank Stock Value
1
GEV icon
GE Vernova
GEV
+$205M
2
LII icon
Lennox International
LII
+$191M
3
NVDA icon
NVIDIA
NVDA
+$169M
4
TSCO icon
Tractor Supply
TSCO
+$157M
5
AAPL icon
Apple
AAPL
+$151M

Sector Composition

Rank Sector Weight
1 Technology 33.69%
2 Consumer Discretionary 12.85%
3 Industrials 12.71%
4 Financials 12.68%
5 Healthcare 9.5%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
VCEL icon
1126
Vericel Corp
VCEL
$2.38B
-9,472
Closed -$403K
VIRC icon
1127
Virco
VIRC
$94.4M
-23,065
Closed -$184K
VYGR icon
1128
Voyager Therapeutics
VYGR
$181M
-27,046
Closed -$84.1K
WD icon
1129
Walker & Dunlop
WD
$1.75B
-40,740
Closed -$2.87M
WHR icon
1130
Whirlpool
WHR
$2.51B
-345,368
Closed -$35M
WK icon
1131
Workiva
WK
$3.33B
-229,343
Closed -$15.7M
WLY icon
1132
John Wiley & Sons Class A
WLY
$2.74B
-45,112
Closed -$2.01M
WOOF icon
1133
Petco
WOOF
$802M
-50,243
Closed -$142K
XERS icon
1134
Xeris Biopharma Holdings
XERS
$1.42B
-181,877
Closed -$849K
XNCR icon
1135
Xencor
XNCR
$1.46B
-521,667
Closed -$4.1M
YEXT icon
1136
Yext
YEXT
$568M
-72,417
Closed -$616K
YMAB
1137
DELISTED
Y-mAbs Therapeutics
YMAB
-142,641
Closed -$643K
ZETA icon
1138
Zeta Global
ZETA
$5.43B
-14,171
Closed -$220K
ZIMV
1139
DELISTED
ZimVie
ZIMV
-158,940
Closed -$1.49M
ZTS icon
1140
Zoetis
ZTS
$32.9B
-10,943
Closed -$1.71M
ALAB icon
1141
Astera Labs
ALAB
$44.7B
-6,690
Closed -$605K
CTNM
1142
Contineum Therapeutics
CTNM
$526M
-17,245
Closed -$68.5K
ONIT
1143
Onity Group
ONIT
$344M
-16,574
Closed -$633K
WBTN
1144
WEBTOON Entertainment Inc
WBTN
$1.25B
-296,795
Closed -$2.69M
LINE
1145
Lineage Inc
LINE
$9.75B
-6,140
Closed -$267K
OS
1146
DELISTED
OneStream Inc
OS
-366,734
Closed -$10.4M
CURB
1147
Curbline Properties
CURB
$3.61B
-108,339
Closed -$2.47M

Similar funds

Jacobs Levy Equity Management's Q3 2025 Portfolio in Review

As of Q3 2025, Jacobs Levy Equity Management held 1,147 positions worth $25.2B, down 1.3% from $25.5B the previous quarter. Its ten largest holdings account for 27% of the portfolio.

Jacobs Levy Equity Management withdrew a net $2.05B in Q3 2025, closing 194 positions and reducing 504 holdings. Its most notable exit was Progressive, an estimated $66.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 34% of assets, up from 32% a quarter earlier, followed by Consumer Discretionary and Industrials.

Against the trend, Jacobs Levy Equity Management opened a new position in Bank of America worth $45M.

  • Jacobs Levy Equity Management's largest Q3 2025 buy was Bank of America: 873,228 shares worth $45M.
  • Jacobs Levy Equity Management added most to Alnylam Pharmaceuticals in Q3 2025, an estimated $160M increase.
  • Jacobs Levy Equity Management's biggest Q3 2025 reduction was GE Vernova, cutting an estimated $205M.
  • Jacobs Levy Equity Management fully exited Progressive in Q3 2025, selling an estimated $66.7M.
  • Jacobs Levy Equity Management's ten largest holdings make up 27% of its $25.2B portfolio in Q3 2025.
  • Jacobs Levy Equity Management opened 127 new positions and closed 194 in Q3 2025.
  • Jacobs Levy Equity Management's portfolio value fell 1.3% quarter-over-quarter to $25.2B.

Based on Jacobs Levy Equity Management's 13F filing for Q3 2025, filed 17 Nov 2025.